EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSG00000111144
Gene: LTA4H
Gene Synonyms:
1 APIs:
16 Enzyme and pathways 7 Cross references
207 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Leukotriene B4 Receptor

Ensembl ID : ENSG00000213903
Gene: LTB4R
Gene Synonyms: BLTR,CMKRL1,GPR16,LTB4R1,P2RY7,P2Y7
4 APIs:
8 Enzyme and pathways 7 Cross references
141 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Leukotriene B4 Receptor 2

Ensembl ID : ENSG00000213906
Gene: LTB4R2
Gene Synonyms: BLT2,BLTR2,JULF2,NOP9
2 APIs:
8 Enzyme and pathways 7 Cross references
238 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Lysine Demethylase 1a

Ensembl ID : ENSG00000004487
Gene: KDM1A
Gene Synonyms: AOF2,BHC110,KDM1,KIAA0601,LSD1
1 APIs:
25 Enzyme and pathways 8 Cross references
215 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Lysyl Oxidase Like 2

Ensembl ID : ENSG00000134013
Gene: LOXL2
Gene Synonyms: LOR,WS9-14
1 APIs:
5 Enzyme and pathways 7 Cross references
288 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSG00000240972
Gene: MIF
Gene Synonyms: GIF,GLIF
2 APIs:
10 Enzyme and pathways 8 Cross references
219 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSG00000164078
Gene: MST1R
Gene Synonyms: CD136,CDW136,PTK8,RON,SEA
3 APIs:
3 Enzyme and pathways 8 Cross references
268 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Maltase-Glucoamylase

Ensembl ID : ENSG00000257335
Gene: MGAM
Gene Synonyms: MGA
4 APIs:
6 Enzyme and pathways 7 Cross references
312 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSG00000257743
Gene: MGAM2
Gene Synonyms:
2 APIs:
6 Cross references
393 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Matrix Metallopeptidase 1

Ensembl ID : ENSG00000196611
Gene: MMP1
Gene Synonyms: CLG
4 APIs:
13 Enzyme and pathways 8 Cross references
348 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Matrix Metallopeptidase 12

Ensembl ID : ENSG00000262406
Gene: MMP12
Gene Synonyms: HME
2 APIs:
3 Enzyme and pathways 7 Cross references
560 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Matrix Metallopeptidase 13

Ensembl ID : ENSG00000137745
Gene: MMP13
Gene Synonyms: CLG3
3 APIs:
11 Enzyme and pathways 8 Cross references
202 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).